We are live on ! Find out more
CIC

Chase Investment Counsel Portfolio holdings

AUM $474M
1-Year Est. Return 95.11%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+95.11%
3 Year Est. Return
+349.64%
5 Year Est. Return
+621.11%
10 Year Est. Return
+3,935.08%
AUM
$206M
AUM Growth
-$1.97M
Cap. Flow
-$12.8M
Cap. Flow %
-6.23%
Top 10 Hldgs %
31.65%
Holding
103
New
17
Increased
11
Reduced
39
Closed
21

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$6.08M
2
IQV icon
IQVIA
IQV
+$5.35M
3
ALB icon
Albemarle
ALB
+$4.63M
4
EQIX icon
Equinix
EQIX
+$3.51M
5
PHM icon
Pultegroup
PHM
+$3.21M

Sector Composition

Rank Sector Weight
1 Technology 18.96%
2 Consumer Discretionary 18.67%
3 Healthcare 15.3%
4 Industrials 8.25%
5 Communication Services 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$425B
$3.65M 1.77%
88,367
-8,345
-9% -$355K
DHR icon
27
Danaher
DHR
$142B
$3.63M 1.76%
48,557
-3,807
-7% -$285K
EQIX icon
28
Equinix
EQIX
$104B
$3.55M 1.72%
+8,278
New +$3.51M
EA
29
DELISTED
Electronic Arts
EA
$3.33M 1.62%
31,551
-2,094
-6% -$216K
CMCSA icon
30
Comcast
CMCSA
$89.9B
$3.22M 1.56%
82,790
-7,168
-8% -$282K
VISN
31
Vistance Networks Inc
VISN
$2.37B
$3.14M 1.52%
82,530
-67,736
-45% -$2.62M
CDK
32
DELISTED
CDK Global, Inc.
CDK
$3.01M 1.46%
48,487
-16,616
-26% -$1.04M
PHYS icon
33
Sprott Physical Gold
PHYS
$15.7B
$2.93M 1.42%
289,699
BCR
34
DELISTED
CR Bard Inc.
BCR
$2.48M 1.2%
7,844
-770
-9% -$229K
BIB icon
35
ProShares Ultra NASDAQ Biotechnology
BIB
$85M
$2.48M 1.2%
46,396
PRAH
36
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.16M 1.05%
28,824
+2,976
+12% +$206K
TMO icon
37
Thermo Fisher Scientific
TMO
$216B
$2.09M 1.02%
11,991
-971
-7% -$163K
SSNC icon
38
SS&C Technologies
SSNC
$18.8B
$1.91M 0.93%
49,675
+18,360
+59% +$684K
CBOE icon
39
Cboe Global Markets
CBOE
$30.2B
$1.73M 0.84%
+18,982
New +$1.62M
CEF icon
40
Sprott Physical Gold and Silver Trust
CEF
$8.02B
$1.53M 0.74%
124,200
-1,820
-1% -$22.9K
BR icon
41
Broadridge
BR
$19B
$1.45M 0.7%
+19,225
New +$1.39M
MAS icon
42
Masco
MAS
$15.2B
$1.43M 0.69%
37,401
+19,121
+105% +$699K
OLLI icon
43
Ollie's Bargain Outlet
OLLI
$4.78B
$1.43M 0.69%
33,487
-9,839
-23% -$385K
COR
44
DELISTED
Coresite Realty Corporation
COR
$1.35M 0.66%
13,083
-42
-0.3% -$4.21K
ON icon
45
ON Semiconductor
ON
$19.1B
$1.28M 0.62%
91,155
+254
+0.3% +$3.82K
LITE icon
46
Lumentum
LITE
$67.8B
$1.25M 0.61%
22,012
-62
-0.3% -$3.32K
LEA icon
47
Lear
LEA
$8.15B
$1.24M 0.6%
8,735
-5,618
-39% -$795K
MCHP icon
48
Microchip Technology
MCHP
$45.3B
$1.2M 0.58%
30,990
+8,270
+36% +$325K
TTEK icon
49
Tetra Tech
TTEK
$8.98B
$1.18M 0.57%
+128,475
New +$1.14M
AVY icon
50
Avery Dennison
AVY
$13.3B
$1.15M 0.56%
+12,980
New +$1.09M

Similar funds

Chase Investment Counsel's Q2 2017 Portfolio in Review

As of Q2 2017, Chase Investment Counsel held 103 positions worth $206M, down 0.95% from $208M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Chase Investment Counsel withdrew a net $12.8M in Q2 2017, closing 21 positions and reducing 39 holdings. Its most notable exit was Paramount Global Class B, an estimated $4.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Chase Investment Counsel opened a new position in Alibaba worth $6.94M.

  • Chase Investment Counsel's largest Q2 2017 buy was Alibaba: 49,257 shares worth $6.94M.
  • Chase Investment Counsel added most to Pultegroup in Q2 2017, an estimated $3.21M increase.
  • Chase Investment Counsel's biggest Q2 2017 reduction was Vistance Networks Inc, cutting an estimated $2.62M.
  • Chase Investment Counsel fully exited Paramount Global Class B in Q2 2017, selling an estimated $4.77M.
  • Chase Investment Counsel's ten largest holdings make up 32% of its $206M portfolio in Q2 2017.
  • Chase Investment Counsel opened 17 new positions and closed 21 in Q2 2017.
  • Chase Investment Counsel's portfolio value fell 0.95% quarter-over-quarter to $206M.

Based on Chase Investment Counsel's 13F filing for Q2 2017, filed 24 Jul 2017.